首页|期刊导航|中华医学杂志（英文版）|Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma

Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma

Zhen-Peng Cao Bao Guan Guang-Zhi Zhao Dong Fang GengoYan Xiong Xue-Song Li Li-Qun Zhou

中华医学杂志（英文版）2017，Vol.130Issue(17)：2063-2068,6.

中华医学杂志（英文版）2017，Vol.130Issue(17)：2063-2068,6.DOI:10.4103/0366-6999.213414

Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma

Zhen-Peng Cao ¹Bao Guan ¹Guang-Zhi Zhao ¹Dong Fang ¹GengoYan Xiong ¹Xue-Song Li ¹Li-Qun Zhou¹

作者信息

1. Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Centre, Beijing 100034, China
折叠

摘要

关键词

Neutrophil-to-Lymphocyte Ratio/Prognosis/Upper Tract Urothelial Carcinoma

Key words

Neutrophil-to-Lymphocyte Ratio/Prognosis/Upper Tract Urothelial Carcinoma

引用本文复制引用

Zhen-Peng Cao,Bao Guan,Guang-Zhi Zhao,Dong Fang,GengoYan Xiong,Xue-Song Li,Li-Qun Zhou..Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma[J].中华医学杂志（英文版）,2017,130(17):2063-2068,6.

基金项目

This work was supported by grants from the Natural Science Foundation of Beijing (No.7152146),the Collaborative Research Foundation of Peking University Health Science Center and National Taiwan University,College of Medicine (BMU20120318),the Clinical Features Research of Capital (No.Z151100004015173),and the Capital Health Research and Development of Special (No.2016-1-4077). （No.7152146）

中华医学杂志（英文版）

OACSCDCSTPCD

ISSN：0366-6999

访问量0

下载量0

段落导航